Your browser doesn't support javascript.
loading
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress.
Martín-Adrados, Beatriz; Wculek, Stefanie K; Fernández-Bravo, Sergio; Torres-Ruiz, Raúl; Valle-Noguera, Ana; Gomez-Sánchez, Maria José; Hernández-Walias, José Carlos; Ferreira, Frederico Moraes; Corraliza, Ana María; Sancho, David; Esteban, Vanesa; Rodriguez-Perales, Sandra; Cruz-Adalia, Aránzazu; Nakaya, Helder I; Salas, Azucena; Bernardo, David; Campos-Martín, Yolanda; Martínez-Zamorano, Elena; Muñoz-López, Diego; Gómez Del Moral, Manuel; Cubero, Francisco Javier; Blumberg, Richard S; Martínez-Naves, Eduardo.
Afiliação
  • Martín-Adrados B; Department of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
  • Wculek SK; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Fernández-Bravo S; Department of Allergy and Immunology, IIS-Fundación Jiménez Díaz, Universidad Autónoma of Madrid, Madrid, Spain.
  • Torres-Ruiz R; Molecular Cytogenetics & Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro, Madrid, Spain.
  • Valle-Noguera A; Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Advanced Therapies Unit, Hematopoietic Innovative Therapies Division, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Gomez-Sánchez MJ; Department of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
  • Hernández-Walias JC; Department of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
  • Ferreira FM; Department of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
  • Corraliza AM; LIM50, Division of Pathology, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
  • Sancho D; Department of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red-Enfermedades Hepáticas y Digestivas (CIBER-EHD), Barcelona, Spain.
  • Esteban V; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Rodriguez-Perales S; Department of Allergy and Immunology, IIS-Fundación Jiménez Díaz, Universidad Autónoma of Madrid, Madrid, Spain.
  • Cruz-Adalia A; Molecular Cytogenetics & Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro, Madrid, Spain.
  • Nakaya HI; Department of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
  • Salas A; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Bernardo D; Department of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red-Enfermedades Hepáticas y Digestivas (CIBER-EHD), Barcelona, Spain.
  • Campos-Martín Y; Gut Immunology Research Group, Instituto de Investigación del Hospital Universitario de la Princesa, Madrid, Spain.
  • Martínez-Zamorano E; Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM, Universidad de Valladolid-Consejo Superior de Investigaciones Científicas (CSIC)), Valladolid, Spain.
  • Muñoz-López D; Centro de Investigaciones Biomédicas en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Gómez Del Moral M; Department of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
  • Cubero FJ; Department of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
  • Blumberg RS; Department of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
  • Martínez-Naves E; Department of Cellular Biology, School of Medicine, Universidad Complutense of Madrid (UCM), Madrid, Spain.
Front Immunol ; 14: 1185517, 2023.
Article em En | MEDLINE | ID: mdl-37457727
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha